NHC (NHC) director reports open-market sale and holds option grants
Rhea-AI Filing Summary
National Healthcare Corp director HASSAN EMIL E reported an open-market sale of 5,937 shares of common stock at $200.00 per share on June 22, 2026, and now directly holds 65,595 shares.
The director also holds multiple stock option grants, each covering 7,500 underlying common shares, with exercise prices ranging from $55.75 to $171.42 and expiration dates from 2027 through 2031. These options represent ongoing equity-based compensation rather than new purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 5,937 shares ($1,187,400)
Net Sell
6 txns
Insider
HASSAN EMIL E
Role
Director
Sold
5,937 shs ($1.19M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Shares of Common Stock | 5,937 | $200.00 | $1.19M |
| holding | Option to Purchase Common Stock [2022 Grant] | -- | -- | -- |
| holding | Option to Purchase Common Stock [2023 Grant] | -- | -- | -- |
| holding | Option to Purchase Common Stock [2024 Grant] | -- | -- | -- |
| holding | Option to Purchase Common Stock [2025 Grant] | -- | -- | -- |
| holding | Option to Purchase Common Stock [2026 Grant] | -- | -- | -- |
Holdings After Transaction:
Shares of Common Stock — 65,595 shares (Direct);
Option to Purchase Common Stock [2022 Grant] — 7,500 shares (Direct);
Option to Purchase Common Stock [2023 Grant] — 7,500 shares (Direct);
Option to Purchase Common Stock [2024 Grant] — 7,500 shares (Direct);
Option to Purchase Common Stock [2025 Grant] — 7,500 shares (Direct);
Option to Purchase Common Stock [2026 Grant] — 7,500 shares (Direct)
Footnotes (1)
Key Figures
Shares sold: 5,937 shares
Sale price per share: $200.00 per share
Shares held after sale: 65,595 shares
+4 more
7 metrics
Shares sold
5,937 shares
Open-market sale of common stock on June 22, 2026
Sale price per share
$200.00 per share
Price for 5,937 shares of common stock sold
Shares held after sale
65,595 shares
Director’s direct common stock holdings post-transaction
2026 option grant size
7,500 shares
Underlying common shares for 2026 option grant
2026 option exercise price
$171.42
Exercise price for 2026 option grant, expiring 2031
2023 option exercise price
$55.75
Exercise price for 2023 option grant, expiring 2028
2022 option exercise price
$69.19
Exercise price for 2022 option grant, expiring 2027
Key Terms
open-market sale, Option to Purchase Common Stock, exercise price, expiration date, +1 more
5 terms
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Option to Purchase Common Stock financial
"security_title: "Option to Purchase Common Stock [2026 Grant]""
exercise price financial
"conversion_or_exercise_price: "171.4200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2031-05-06T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: "Common Stock""
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did NHC director HASSAN EMIL E report?
The director reported an open-market sale of 5,937 shares of National Healthcare Corp common stock at $200.00 per share. This transaction is disclosed on a Form 4 insider filing as required for directors of public companies.
What stock options does the NHC director hold according to this Form 4?
The director holds several option grants, each for 7,500 underlying common shares, labeled 2022 through 2026 grants. Exercise prices range from $55.75 to $171.42, with expiration dates between 2027 and 2031, reflecting multi-year equity compensation awards.
Were any NHC stock options exercised in this insider filing?
No stock option exercises are reported in this Form 4. The filing lists the option grants as holdings, with exercise prices and expiration dates, but shows no derivative transaction codes indicating exercises or conversions of these options into common shares.
Is the NHC director’s sale classified as an open-market transaction?
Yes, the 5,937-share transaction is classified as an open-market sale. The Form 4 identifies the transaction code as “S” with a description stating it is a sale in the open market or a private transaction, both treated as dispositions.